Drug profile · INN
metformin hydrochloride
QTRILMET
metformin hydrochloride (QTRILMET) is a mitochondrial complex i (nadh dehydrogenase) inhibitor. Associated with Takeda. Route of administration: oral. Current US regulatory status: approved.
Drug details — metformin hydrochloride
- US status
- approved
- Class
- Alimentary tract and metabolism (A10)
- Route
- ORAL
- Patents
- 15
- Programs
- 12
- Data quality
- 0.89
Quick answer
metformin hydrochloride (QTRILMET) is a mitochondrial complex i (nadh dehydrogenase) inhibitor. Associated with Takeda. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Mitochondrial complex I (NADH dehydrogenase) inhibitor
Primary target: Mitochondrial complex I (NADH dehydrogenase)
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | withdrawn | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12428406
Methods and compounds for restoring mutant p53 function
granted -
US 12419880
Companion diagnostic tool for mutant p53 reactivating compounds
granted -
US 11963953
Deuterated compounds for restoring mutant p53 function
granted -
US 11926632
Methods and compounds for restoring mutant p53 function
granted -
US 11814373
Methods and compounds for restoring mutant p53 function
granted -
US 11807644
Methods and compounds for restoring mutant p53 function
granted -
US 11731953
Methods and compounds for restoring mutant p53 function
granted -
US 11339141
Methods and compounds for restoring mutant p53 function
granted -
US 10668021
Metformin hydrochloride osmotic pump tablet and preparation method therefor
granted -
US 10640485
Methods and compounds for restoring mutant p53 function
granted -
US 10138219
Methods and compounds for restoring mutant p53 function
granted -
US 9320714
Tablet
granted -
US 9101660
Solid preparation
granted -
US 8900638
Solid preparation comprising alogliptin and metformin hydrochloride
granted -
US 7807689
Dipeptidyl peptidase inhibitors
granted
Frequently asked questions
What is metformin hydrochloride?
metformin hydrochloride (QTRILMET) is a mitochondrial complex i (nadh dehydrogenase) inhibitor. Associated with Takeda. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for metformin hydrochloride?
QTRILMET is a marketed brand name for metformin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of metformin hydrochloride?
metformin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.